Cargando…
PHLDA1 Expression is Controlled by an Estrogen Receptor (ER)-NFκB-miR-181 Regulatory Loop and is Essential for Formation of ER+ Mammospheres
Crosstalk between estrogen receptor (ER) and the inflammatory nuclear factor κB (NFκB) pathway in ER+ breast cancers may contribute to a more aggressive phenotype. PHLDA1 (Pleckstrin Homology-Like Domain, Family A, member 1), one target gene of ER-NFκB crosstalk, has been implicated in cell survival...
Autores principales: | Kastrati, Irida, Canestrari, Emanuele, Frasor, Jonna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275416/ https://www.ncbi.nlm.nih.gov/pubmed/24954507 http://dx.doi.org/10.1038/onc.2014.180 |
Ejemplares similares
-
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors
por: Semina, Svetlana E., et al.
Publicado: (2022) -
A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties
por: Kastrati, Irida, et al.
Publicado: (2015) -
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells
por: Semina, Svetlana E., et al.
Publicado: (2022) -
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas
por: Emmadi, Rajyasree, et al.
Publicado: (2015) -
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer
por: Msheik, Zahraa S., et al.
Publicado: (2022)